References
- Asai A, Miyazawa T. Occurrence of orally administered curcuminoid as glucuronide and glucuronide/sulfate conjugates in rat plasma. Life Sciences 2000; 67: 2785–2793
- Coughtrie MWH, Sharp S, Maxwell K, Innes NP. Biology and function of the reversible sulfation pathway catalysed by human sulfotransferases and sulfatases. Chemico-Biological Interactions 1998; 109: 3–27
- Fröhlich AK, Girreser U, Clement B. Metabolism of benzamidoxime (N-hydroxyamidine) in human hepatocytes and role of UDP-glucuronosyl transferases. Xenobiotica 2005; 35: 17–25
- Lee J, La S, Ahn BR, Jeong TC, Kim DH. Metabolism of 1-{3-[3-(4-cyanobenzyl)-3H-imidazol-4-yl]-propyl}-3-(6-methoxypyridin-3-yl)-1-(2-trifluoromethylbenzyl) thiourea (YH3945), a novel anti-cancer drug, in rats using the 14C-labeled compound. Rapid Communications in Mass Spectrometry 2004c; 18: 1901–1910
- Lee SH, Kim SI, Park JG, Lee ES, Jahng Y. A simple synthesis of rutaecarpine. Heterocycles 2001; 55: 1555–1559
- Lee SK, Kim NH, Lee J, Kim DH, Lee ES, Choi HG, Chang HW, Jahng Y, Jeong TC. Induction of cytochrome P450s by rutaecarpine and metabolism of rutaecarpine by cytochrome P450s. Planta Medica 2004a; 70: 753–757
- Lee SK, Lee J, Lee ES, Jahng Y, Kim DH, Jeong TC. Characterization of in vitro metabolites of rutaecarpine in rat liver microsomes using liquid chromatography/tandem mass spectrometry. Rapid Communications in Mass Spectrometry 2004b; 18: 1073–1080
- Moon TC, Murakami M, Kudo I, Son KH, Kang SS, Chang HW. A new class of COX-2 inhibitor, rutaecarpine from Evodia rutaecarpa. Inflammation Research 1999; 48: 621–625
- Parkinson A. Biotransformation of xenobiotics. Casarett and Doull's toxicology: The basic science of poisons. 6th ed, CD Klaassen. McGraw-Hill, New York, NY 2001; 133–224
- Rendic S, Dicarlo FJ. Human cytochrome P450 enzymes: A status report summarizing their reactions, substrates, inducers and inhibitors. Drug Metabolism Reviews 1997; 29: 413–580
- Ueng YF, Jan WC, Lin LC, Chen TL, Guengerich FP, Chen CF. The alkaloid rutaecarpine is a selective inhibitor of cytochrome P450 1A in mouse and human liver microsomes. Drug Metabolism and Disposition 2002a; 30: 349–353
- Ueng YF, Ko HC, Chen CF, Wang JJ, Chen KT. Modulation of drug-metabolizing enzymes by extracts of a herbal medicine Evodia rutaecarpa in C57BL/6J mice. Life Sciences 2002b; 71: 1267–1277
- Ueng YF, Wang JJ, Lin LC, Park SS, Chen CF. Induction of cytochrome P450-dependent monooxygenase in mouse liver and kidney by rutaecarpine, an alkaloid of the herbal drug Evodia rutaecarpa. Life Sciences 2001; 70: 207–217
- Ueng YF, Yu HJ, Lee CH, Peng C, Jan WC, Ho LK, Chen CF, Don MJ. Identification of the microsomal oxidation metabolites of rutaecarpine, a main active alkaloid of the medicinal herb Evodia rutaecarpa. Journal of Chromatography A 2005; 1076: 103–109